These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36041353)

  • 1. Smartphone-assisted psychoeducation in adult attention-deficit/hyperactivity disorder: A randomized controlled trial.
    Selaskowski B; Steffens M; Schulze M; Lingen M; Aslan B; Rosen H; Kannen K; Wiebe A; Wallbaum T; Boll S; Lux S; Philipsen A; Braun N
    Psychiatry Res; 2022 Nov; 317():114802. PubMed ID: 36041353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chatbot-supported psychoeducation in adult attention-deficit hyperactivity disorder: randomised controlled trial.
    Selaskowski B; Reiland M; Schulze M; Aslan B; Kannen K; Wiebe A; Wallbaum T; Boll S; Lux S; Philipsen A; Braun N
    BJPsych Open; 2023 Oct; 9(6):e192. PubMed ID: 37827996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile app-based chatbot to deliver cognitive behavioral therapy and psychoeducation for adults with attention deficit: A development and feasibility/usability study.
    Jang S; Kim JJ; Kim SJ; Hong J; Kim S; Kim E
    Int J Med Inform; 2021 Jun; 150():104440. PubMed ID: 33799055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial.
    Selaskowski B; Staerk C; Braun N; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Huss M; Jans T; Tebartz van Elst L; Berger M; Lux S; Mayr A; Philipsen A
    J Psychiatr Res; 2022 Jul; 151():225-234. PubMed ID: 35500450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.
    Svanborg P; Thernlund G; Gustafsson PA; Hägglöf B; Poole L; Kadesjö B
    Eur Child Adolesc Psychiatry; 2009 Apr; 18(4):240-9. PubMed ID: 19156355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.
    Lopez PL; Torrente FM; Ciapponi A; Lischinsky AG; Cetkovich-Bakmas M; Rojas JI; Romano M; Manes FF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010840. PubMed ID: 29566425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychoeducational group interventions for adults diagnosed with attention-deficit/ hyperactivity disorder: a scoping review of feasibility, acceptability, and outcome measures.
    Skliarova T; Pedersen H; Holsbrekken Å; Pedersen SA; Mandal A; De Las Cuevas C; Havnen A; Gråwe R; Lara-Cabrera ML
    BMC Psychiatry; 2024 Jun; 24(1):463. PubMed ID: 38902683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.
    Hoxhaj E; Sadohara C; Borel P; D'Amelio R; Sobanski E; Müller H; Feige B; Matthies S; Philipsen A
    Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):321-335. PubMed ID: 29356899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study.
    Vidal R; Bosch R; Nogueira M; Gómez-Barros N; Valero S; Palomar G; Corrales M; Richarte V; Mena B; Casas M; Ramos-Quiroga JA
    J Nerv Ment Dis; 2013 Oct; 201(10):894-900. PubMed ID: 24080677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial.
    Haugan AJ; Sund AM; Young S; Thomsen PH; Lydersen S; Nøvik TS
    BMC Psychiatry; 2022 Jun; 22(1):375. PubMed ID: 35655149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial.
    Ferrin M; Moreno-Granados JM; Salcedo-Marin MD; Ruiz-Veguilla M; Perez-Ayala V; Taylor E
    Eur Child Adolesc Psychiatry; 2014 Aug; 23(8):637-47. PubMed ID: 24292412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of the FOCUS ADHD App in monitoring adults with attention-deficit/hyperactivity disorder.
    Carvalho LR; Haas LM; Zeni G; Victor MM; Techele SP; Marrone Castanho J; Meneghetti Coimbra I; de Freitas de Sousa A; Ceretta N; Garrudo A; Grevet EH; Rohde LA
    Eur Psychiatry; 2023 Jun; 66(1):e53. PubMed ID: 37341028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Trial Evaluating the Efficacy of a Psychoeducation Program for Families of Children and Adolescents With ADHD in the United Kingdom: Results After a 6-Month Follow-Up.
    Ferrin M; Perez-Ayala V; El-Abd S; Lax-Pericall T; Jacobs B; Bilbow A; Taylor E
    J Atten Disord; 2020 Mar; 24(5):768-779. PubMed ID: 26838557
    [No Abstract]   [Full Text] [Related]  

  • 19. What adults with ADHD want to know: A Delphi consensus study on the psychoeducational needs of experts by experience.
    Seery C; Wrigley M; O'Riordan F; Kilbride K; Bramham J
    Health Expect; 2022 Oct; 25(5):2593-2602. PubMed ID: 35999687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.